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SUMMARY
This paper reports the isolation of St. Louis encephalitis virus (SLEV) from a febrile human case suspected to be dengue, in
São Pedro, São Paulo State. A MAC-ELISA done on the patient’s acute and convalescent sera was inconclusive and hemagglutination
inhibition test detected IgG antibody for flaviviruses. An indirect immunofluorescent assay done on the C6/36 cell culture inoculated
with the acute serum was positive for flaviviruses but negative when tested with dengue monoclonal antibodies. RNA extracted
from the infected cell culture supernatant was amplified by RT-PCR in the presence of NS5 universal flavivirus primers and
directly sequenced. Results of BLAST search indicated that this sequence shares 93% nucleotide similarity with the sequence of
SLEV (strain-MSI.7), confirmed by RT-PCR performed with SLEV specific primers. Since SLEV was identified as the cause of
human disease, it is necessary to improve surveillance in order to achieve early detection of this agent in the state of São Paulo and
in Brazil. This finding is also an alert to health professionals about the need for more complete clinical and epidemiological
investigations of febrile illnesses as in the reported case. SLEV infections can be unrecognized or confused with other ones caused
by an arbovirus, such as dengue.
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INTRODUCTION
Saint Louis encephalitis virus (SLEV) is an arthropod-borne virus
and a member of the Japanese encephalitis virus complex within the
genus Flavivirus, family Flaviviridae3. SLEV prototype strain (Parton)
was isolated in 1933, in Saint Louis, Missouri, USA, from suspensions
of brain specimens from deceased patients, by intracerebral inoculation
of rhesus monkeys and white mice20. In 1941/42, HAMMON et al.
established the involvement of wild birds as reservoir hosts and Culex
mosquitoes as vectors of the virus20.
SLEV is widespread in the Americas and it has been detected from
Canada to Argentina. Clinical manifestations range from non-apparent
infection to severe cases of encephalitis24. Severity of illness increases
with advancing age and approximately 90% of the cases in the elderly
lead to encephalitis. Case-fatality rates during epidemics have ranged
from 5 to 20%, increasing with age24.
The virus was first isolated in northern Brazil in 1969 from a pool
of Sabethes belisarioi mosquitoes collected along the Belém-Brasília
highway4. Despite the wide distribution of SLEV in the Amazon region,
verified by serological evidence in birds and humans, to date no
epidemic of encephalitis due to the virus has been detected in the region,
unlike in the USA where the virus has caused numerous encephalitis
outbreaks17.
In Brazil only two isolates of SLEV were obtained from human
blood, both in the Amazon region, in 1971 and 1978. In both instances,
the clinical picture was characterized by a febrile illness with jaundice;
no signs of CNS involvement were observed16,24.
In the State of São Paulo, between 1967 and 1969, eight SLEV
isolations were obtained from rodents, birds and sentinel mice6.
Neutralizing antibodies (N) were detected by DE SOUZA LOPES et
al.6 in humans from areas where the virus was isolated, and by
IVERSSON et al.9,10 in the Ribeira Valley region in 1977, 1978 and
1980. FERREIRA et al.7 found monotypic hemagglutination inhibition
(HI) antibodies to SLEV in 49 species of wild birds from the Atlantic
forest belonging to 19 families, many of them with migratory habits.
Serological inquiries conducted by ROMANO-LIEBER &
IVERSSON21 in the Ribeira Valley in 1990 showed, the prevalence of
SLEV neutralizing antibodies in residents of ecological reserve Juréia-
Itatins. No other isolations were obtained until 1993 when the virus
was recovered from Anopheles triannulatus and Culex (culex) spp.
mosquitoes, collected in the Northwest region of São Paulo (Akemi
Suzuki, Adolfo Lutz Institute, unpublished data). In 1996 a
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seroconversion to SLEV was observed by hemagglutination-inhibition
(HI) and neutralization (N) tests in a patient suspected of having an
arbovirus illness in the Ribeira Valley5.
This work reports the first isolation of SLEV in the State of São
Paulo from the blood of a human case and the results of the laboratory
investigations in relation to the case. Dengue (DENV) was suspected
initially based on the symptoms, but there was no epidemiological or
laboratory evidence to support this diagnosis. Thus, other laboratory
investigations were carried out to identify the etiological agent.
MATERIAL AND METHODS
Patient: On January 21, 2004, a 53-year-old female, physician,
was admitted to “Nove de Julho Hospital” in the city of São Paulo for
a febrile illness. Symptoms beginning on Jan. 18 included: fever, severe
headaches, myalgia, retro orbital pains, somnolence, nausea, vomiting,
and a macular rash on the face, neck and thorax, that lasted for one
day, and pruritis, mainly on palms and soles. The initial clinical
diagnosis was “probable dengue fever”.
The patient resided in São Paulo, SP, in an area without Aedes
aegypti, but she owns a country house in São Pedro, 180 km Northeast
of São Paulo. Despite the presence of Aedes aegypti in the latter region,
no DENV autochthonous transmission had been detected there. She
had spent the weekend there nine days before her symptoms began.
An acute blood sample was drawn for tests: hemogram, AST, ALT
and GGT. The only alterations observed were the levels of AST (85U/
L), ALT (86U/L) and GGT (137U/L). Specific serological assays were
negative for rubella, toxoplasmosis and cytomegalovirus. The patient
had fever for seven days and except for severe headaches, no signs of
CNS disease were observed. She recovered completely and was
discharged after four days of hospitalization.
Laboratory investigation: Acute and convalescent phase serum
samples (SPH 253175), taken three and 25 days after onset of illness
respectively, were sent to the laboratory of the Center of Zoonosis
Control, where the MAC-ELISA for dengue IgM was performed.
Because the result was considered inconclusive, the samples were sent
to Adolfo Lutz Institute for further serological tests. MAC-ELISA for
flavivirus IgM antibodies was performed using the four dengue antigens
following the procedure described by KUNO et al.12. Serologic assay
for IgG antibodies was done by hemagglutination inhibition (HI) with
acetone-extracted serum samples22, using Dengue serotypes 1, 2 and
3, Ilheus (ILHV), Rocio (ROCV), Yellow fever (YFV) and SLEV
flavivirus antigens. Eastern equine encephalitis virus alphavirus antigen
was used as negative control.
The first serum sample was inoculated into monolayer cultures of
C6/36 Aedes albopictus cells (20 µL/tube) in an attempt to isolate
DENV. The cell culture was incubated for nine days at 28 °C. Indirect
immunofluorescent antibody (IFA) tests were performed using
flavivirus polyclonal antibodies, as well as dengue monoclonal
antibodies provided by the U.S. Centers for Disease Control and
Prevention, for identification8. The first serum sample and the infected
C6/36 cell culture supernatant were also inoculated intracerebrally (i.c.)
into litters of six newborn Swiss albino mice for virus isolation. The
mice were observed daily for signs of illness. Suspensions of infected
mouse brain were tested by neutralization (N) assay in mice1 using
serial dilutions of the brain suspensions (virus) with undiluted
hyperimmune ascitic fluid of SPH 253175, Dengue 1 (DENV-1), Iguape
(IGUV), ILHV, ROCV, YFV and SLEV. A serum sample from the
convalescent phase was tested against its own virus by N.
Molecular studies: Viral RNA was isolated from virus-infected
C6/36 culture supernatant using the QIAmpViral RNA Extraction Kit
(QIAGEN, Valencia, CA, USA), according to manufacturer’s
instructions.
Reverse-transcription and amplification reactions (RT-PCR)
employed the flavivirus universal primers MA/cFD213; FU2/cFD2, FU3/
cFD314. Specific primers for SLEV and West Nile virus (WNV) were
also used (Table 1). RT-PCR was conducted in a single reaction tube
using the SuperScriptTM One-Step RT-PCR System with PlatiniumR
Taq DNA Polymerase (Invitrogen, Carlsbad, CA, USA) in the presence
of 4 µL of viral RNA and 10 pMol of each primer pair in a total reaction
volume of 25 µL. Reverse transcription was performed at 50 oC for 30
min. After a 3-min denaturation step at 94 oC, cycling times and
temperatures proceeded as follows: 30 cycles of 94 oC for 30 sec, 45 oC
for 30 sec and 72 oC for one min in reactions containing NS5 gene
primers of Flavivirus genus; 40 cycles of 94 oC for 30 sec, 60 oC for
one min, 72 oC for two min, in reactions employing SLEV or WNV
primers. A final extension at 72 oC for seven min was included in both
profiles. The amplification products were analyzed by electrophoresis
in a 1.5% agarose gel, and the separated fragments were visualized by
ethidium bromide staining.
The products generated in the RT-PCR reactions with the flavivirus
universal primers MA/cFD2, FU2/cFD2 and FU3/cFD3 were directly
sequenced using the “ABI Prism Big Dye Terminator Cycle Sequencing
Ready Reaction Kit” (PE Applied Biosystems, Foster City, CA, USA)
following manufacturer’s protocol. Nucleic acid sequence analysis was
performed on an automated Applied Biosystems 377 DNA sequencer.
Sequence data from this study has been deposited with GenBank
Data Libraries under Accession Number AY825077.
Eco-epidemiological studies: Wild birds were captured with mist
Table 1
Oligonucleotide primers used in RT-PCR for SLEV and WNV differentiation
Primer1 Genome Sequence (5’ – 3’)
position2
SLEpme75 727-750 GTAGCCGACGGTCAATCTCTGTGC
SLEpme467 1119-1096 ACTCGGTAGCCTCCATCTTCATCA
WN212 233-257 TTGTGTTGGCTCTCTTGGCGTTCTT
WN619 640-616 CAGCCGACAGCACTGGACATTCATA
WN9483 9504-9528 CACCTACGCCCTAAACACTTTCACC
WN9794 9816-9791 GGAACCTGCTGCCAATCATACCATC
1
 Taller de Vigilancia y Diagostico del Virus del Nilo Occidental, Pergamino,
Argentina, 2003. 2 Genome position of SLEV and WNV specific primers are
according to the sequences in GeneBank, respectively: SLE MSI.7 (accession
number M16614) and WN NY99 (accession number AF196835).
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nets set up for three days, from May 18 to 22, 2004 on the boundaries
of and inside forests in a wooded area of about 50,000 m2 and also
around patient’s dwelling in São Pedro. The birds were bled by puncture
of the jugular vein, identified, banded and released. The blood samples
were collected (0.3 mL) into a sterile syringe containing 1.2 mL of
0.75% phosphate buffered bovine albumin at pH 7.4 and heparin.
Plasmas were separated by centrifugation and used for HI test with 2-
fold dilutions starting at 1 in 20. In attempt to virus isolation plasmas
were also inoculated i.c. into newborn mice. Families of sentinel mice
(one mother and six newborns) were exposed for three days in the
same places where the birds were captured and then placed under
laboratory observation for 21 days.
Mosquitoes were collected at night using CDC light-traps. The
mosquitoes were identified, ground in phosphate buffered salina, pH
7.4 with 1.8% bovine albumin. After centrifugation at 11.000x g for
30 minutes the supernatants were inoculated i.c. into newborn mice.
RESULTS
The convalescent phase serum diluted 1:40 presented optical density
(OD) of 0.142 by MAC ELISA. An OD ≥ 0.200 is considered positive,
while values between 0.100 and 0.200 are the limits. Seroconversion
for flavivirus group IgG antibodies was demonstrated by HI (Table 2).
No cytopathic effect was observed in C6/36 cells after nine days.
An IFA test on some of the cells was positive for flavivirus, but negative
for the four DENV serotypes, using monoclonal antibodies.
RNA extracted from the infected C6/36 cell culture supernatant
was amplified by RT-PCR in the presence of the flavivirus universal
primers, MA/cFD2, FU2/cFD2, FU3/cFD313,14, designed to cover
approximately 1 kb at the 3’ terminus of the NS5 gene of the Flavivirus
genus. Specific amplified products were generated in the RT-PCR
reactions allowing direct sequencing reactions. A fragment of 1020
nucleotides was obtained, after assembling the sequences of the three
overlapping fragments. Results of the BLAST search indicated that
this sequence shared 93% nucleotide similarity with the published
sequence of the Mississippi 1975 SLEV strain-MSI.7 (GenBank
accession number AF013416). To confirm that RNA isolated from the
patient was from SLEV, a RT-PCR assay was performed with primers
designed to specifically differentiate between SLEV and WNV
infection. As shown in Fig. 1, strong amplification of the expected
fragment of 392 bp was obtained with the SLEV primer set. No
amplifications of WNV sequences were observed.
The virus was isolated successfully in suckling mice. The onset of
symptoms was on day 3 after inoculation, two mice were collected on
the 5th day and two more on the 6th day, on day seven the last two died.
Results of mouse N tests showed that the strongest cross-reaction
occurred with the virus isolated and the standard strain of SLEV, with
a log of neutralization index (LNI) of 3.9. A low level of cross-reactivity
occurred with DENV, IGUV, ILHV, ROCV and YFV, with a LNI from
0.9 to 1.8. The patient convalescent serum presented a LNI of 1.9 to
the isolated virus (Table 3).
A total of 47 plasma samples from wild birds belonging to families
Emberezinae (14), Columbidae (8), Turdidae (6), Formicariidae (5),
Tyrannidae (5), Trochilidae (4), Furnariidae (3), Pipridae (1) and
Troglodytidae (1) were tested. All plasma samples were negative by HI
assay. Four hundred and eighty-two mosquitoes belonging to Culex (Cux)
sp. (380), Mansonia (Man) sp. (63), Aedes sp. (20), Ochlerotatus scapularis
(14), Coquillettidia sp. (4) and Anopheles (Nys) sp. (1) were captured. No
virus was isolated from birds, mosquitoes or the sentinel mice.
Fig. 1 - Agarose gel electrophoresis analysis of RT-PCR products from RNA extracted from
supernatant of C6/36 cells infected with patient’s acute phase serum, with the following
primers pairs: (1) WN212/WN619c; (2) WN9483/WN9794; (3) SLEPme75/SLEPme467c);
(M) 1 kb plus DNA Ladder (InvitrogenTM , Carlsbad, CA, USA) molecular marker.
Table 2
Results of the HI tests done on the patients with various arbovirus antigens
Patient sera Antigens
EEEV DENV-1 DENV-2 DENV-3 ILHV ROCV SLEV YFV
Acute 0 0 0 0 0 0 0 0
Convalescent 0 80 20 160 1,280 80 640 160
EEEV = eastern equine encephalitis virus (SPAn 14723); DENV-1 = dengue virus type 1 (Hawaii); DENV-2 = dengue virus type 2 (TR 1751); DENV-3 = dengue virus
type 3 (H 87); ILHV = Ilheus virus (BeH 7445); ROCV = Rocio virus (SPH 34675); SLEV = Saint Louis encephalitis virus (SPAn 11916); YFV = Yellow fever virus
(BeH 111).
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DISCUSSION
This is the first isolation of SLEV from a human case in the State
of São Paulo, Brazil. It seems likely that the infection was acquired in
São Pedro, where the patient stayed nine days prior to onset of illness.
This finding is also an alert to health professionals about the need for
more complete clinical and epidemiological investigations of febrile
illnesses such as in the reported case. Some of the symptoms presented
by the patient, such as rash and pruritis on palms and soles are not
described in the literature. It is unlikely that this case was the only
one; the virus may be circulating silently, or causing clinical symptoms
similar to those observed in DENV. Such cases could easily be
unrecognized or confused with other arbovirus infections. In the State
of São Paulo there are many regions in which there is DENV
transmission, and the symptoms in this case were much more similar
to those described for DENV than the clinical picture described in the
literature for SLEV infection.
SLEV antibodies have been detected in the State more frequently
in the Ribeira Valley region5,6,7,9,10,21, where in the 70’s ROCV virus
was isolated and caused a severe encephalitis epidemic. However, no
clinical cases of SLEV infection were observed. SLEV isolation from
mosquitoes in the northwest of the state and the related case
demonstrated that the virus has been circulating in other regions of the
state.
The clinical picture for SLEV is diverse. Human cases have been
documented in the United States since 193320, varying from mild
sporadic cases to outbreaks of severe encephalitis. An exception of
this pattern is the Coachella Valley in southern California where SLEV
has been also detected regularly, but clinical disease has not been
reported18,19. In Brazil clinical cases of SLEV are rarely recognized, in
spite of the fact that the virus circulates in birds, mosquitoes and
humans5,6,7,9,10,17,21,25. One of the possible explanations for these distinct
dynamics could be the strain virulence. Phenotypic variations between
strains have been described2,11,15,23,24.
Specific primers for WNV were employed in RT-PCR because of
the antigenic relationship between SLEV and WNV. The introduction
of the latter virus into Brazil had to be considered since WNV has
caused epidemics in North America and can be transported by means
of migration of viremic birds.
The field sampling was insufficient to allow a definitive conclusion
about the presence of SLEV in the area and further studies are required
to elucidate the natural transmission cycle of the virus in the region.
The present case is very important since SLEV was identified as the
cause of human disease and points out the necessity to improve
surveillance in order to achieve early detection of this agent in the
state of São Paulo and in Brazil.
RESUMO
Vírus da encefalite São Luis: primeiro isolamento de humano no
Estado de São Paulo, Brasil
O presente estudo relata o isolamento do vírus da encefalite São
Luis (SLEV) de um caso febril humano suspeito de dengue, em São
Pedro, Estado de São Paulo. MAC-ELISA realizado com soros das
fases aguda e convalescente foi inconclusivo e anticorpos IgG foram
detectados por inibição da hemaglutinação para flavivirus.
Imunofluorescência indireta com cultura de células C6/36 inoculadas
com soro da fase aguda foi positivo para flavivirus mas negativo quando
testado com anticorpos monoclonais para dengue. O RNA extraído de
cultura de células infectadas foi amplificado na presença de primers
universais para o gênero Flavivirus, deduzidos de uma região da
proteína não estrutural 5 e diretamente sequenciado. Os resultados da
pesquisa no BLAST indicaram que a seqüência apresenta 93% de
similaridade de nucleotídeos com a seqüência de SLEV (cepa MS1.7),
confirmado por RT-PCR, realizado com primers específicos para SLEV.
O fato de SLEV ter sido identificado como a causa de doença humana
indica a necessidade de aprimorar a vigilância a fim de detectar
precocemente esse agente no Estado de São Paulo e no Brasil. Esse
caso é também um alerta para os profissionais de saúde sobre a
necessidade de investigações clínicas e epidemiológicas mais completas
sobre doenças febris como no caso relatado. Infecções por SLEV podem
não ser reconhecidas ou confundidas com outras causadas por arbovírus
como a dengue.
Table 3
Results of mouse neutralization tests showing the relationship of the isolated virus (SPH 253175) and other flavivirus
Immune sera Virus
SPH 253175 SLEV ROCV ILHV IGUV YFV DENV-1
SPH 2531751 1.9 - - - - - -
SPH 253175 3.5 - - - - - -
SLEV 3.9 3.7 - - - - -
ROCV 1.7 - 3.6 - - - -
ILHV 1.8 - - 3.6 - - -
IGUV 1.8 - - - 4.5 - -
YFV 1.8 - - - - 4.3 -
DENV-1 0.9 - - - - - 3.6
Values represent log of the neutralization index (LNI): 1convalescent phase serum; SLEV = Saint Louis encephalitis virus (SPAn 11916); ROCV = Rocio virus (SPH
34675); ILHV = Ilheus virus (BeH 7445); IGUV = Iguape virus (SPAn 71686); YFV = Yellow fever virus (BeH 111); DENV-1 = dengue virus type 1 (Hawaii); - = not
tested.
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